Bright Minds Biosciences share price logo

Bright Minds Biosciences

NASDAQ: DRUG

Small Cap

$60.98

-0.57

(-0.93%)

as on

Bright Minds Biosciences Stock Performance

as on September 19, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $60.50
    $62.11
    downward going graph

    0.79%

    Downside

    1.85%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $44.28
    $123.75
    downward going graph

    27.39%

    Downside

    102.94%

    Upside

    downward going graph

Bright Minds Biosciences share price movements today

Previous Close
$61.55
Open
$61.00
Volume
127.6K
Market Cap
$580.0M
Day's Low - High
$60.50 - $62.11
52 Week Low - High
$44.28 - $123.75

Bright Minds Biosciences Historical Returns

1 Month Return
-27.37 %
3 Month Return
+ 1.47 %
1 Year Return
+ 15.52 %
3 Year Return
+ 3478.49 %
5 Year Return
0 %

Bright Minds Biosciences Stock Fundamentals & Key Indicators

Check Bright Minds Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$580.0M

EPS (TTM)

-2.76

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-28.87

Industry PE ratio

-6.87

PEG Ratio

0.3878065680978145

EBITDA

-33.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-12.56%

Bright Minds Biosciences Stock Valuation

Track how Bright Minds Biosciences P/E has moved over time to understand its valuation trends.

Bright Minds Biosciences in the last 5 years

  • Overview

  • Trends

Lowest (-47.44x)

September 30, 2025

Today (-47.44x)

September 30, 2025

Industry (-6.87x)

September 30, 2025

Highest (-1.08x)

September 30, 2023

LowHigh

Today’s Price to Earnings Ratio: -47.44x

Bright Minds Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bright Minds Biosciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$580.0MNA-28.870.00%0.00%
BUY$63.1B-63.24%-19.81-12.57%0.00%
BUY$130.1B174.21%29.8186.04%0.00%
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for Bright Minds Biosciences Stock including INR - Dollar returns

The Bright Minds Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Bright Minds Biosciences investment value today

Current value as on today

₹1,24,559

Returns

₹24,559

(+24.56%)

Returns from Bright Minds Biosciences Stock

₹14,452 (+14.45%)

Dollar Impact

₹10,107 (+10.11%)

Analyst Recommendation on Bright Minds Biosciences Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Bright Minds Biosciences. Average target price of $168.38

Bright Minds Biosciences Share Price Target

Get share price movements and forecasts by analysts on Bright Minds Biosciences.

What analysts predicted

63.78%UPSIDE

Target Price

$168.38

Current Price

$60.98

Analyzed by

3 Analysts

Target

$168.38

Bright Minds Biosciences target price $168.38, a slight upside of 63.78% compared to current price of $60.98. According to 3 analysts rating.

Indian Investors' Interest in Bright Minds Biosciences Stock

Search interest for Bright Minds Biosciences Stock has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-9% versus previous 30 day period

Bright Minds Biosciences Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
0
0
Operating Income
-1
0
0
-1
-3
-3
-5
-6
-15
-11
EBITDA
-1
0
0
0
-2
-5
-4
-7
-10
-11
Interest Expense
-
-
-
-
-
-
-
-
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
0
0
0
-2
-5
-4
-7
-10
-2
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-1
0
0
0
-2
-5
-4
-7
-10
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Bright Minds Biosciences Annual Profit & Loss

All numbers in Millions USD

Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Dec 2024
Sep 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
Operating Income
0
0
-8
-14
-7
-2
-13
EBITDA
-
-
0
-14
-7
-2
-12
Interest Expense
-
-
-
-
-
-
-
Depreciation
0
0
8
0
0
0
0
Income Before Tax
0
0
-8
-14
-7
-2
-12
Income Tax Expense
-
-
-
-
-
-
-
Net Income
0
0
-8
-14
-7
-2
-12
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Bright Minds Biosciences Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-1
0
0
0
-2
-5
-4
-7
-10
-2
Operating Cash Flow
0
0
0
-1
-2
-3
-1
-5
-9
-8
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
0
0
0
52
0
0
33
13
232
-2
Change in Cash
0
0
0
52
-2
-4
31
6
218
-7

Bright Minds Biosciences Annual Cash Flow

All numbers in Millions USD

Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Dec 2024
Sep 2025
Net Income
0
0
-8
-14
-7
-2
-12
Operating Cash Flow
0
0
-7
-13
-7
-1
-8
Investing Cash Flow
-
-
-
-
-
-
-
Financing Cash Flow
0
1
26
5
2
0
85
Change in Cash
0
0
18
-8
-4
-1
77

Mutual Funds that own Bright Minds Biosciences Stock

Check out the Mutual Funds with significant holdings in Bright Minds Biosciences.

Funds
Holdings
Shares Held
MUTUAL FUND SERIES TRUST
1.318047%
130013
BlackRock Funds
0.969732%
95655
Fidelity Salem Street Trust
0.754009%
74376
Driehaus Mutual Funds
0.425848%
42006
VANGUARD SCOTTSDALE FUNDS
0.304448%
30031

Global Institutional Holdings in Bright Minds Biosciences

Funds
Holdings
Richard Driehaus
4.39%
Joseph Edelman
3.83%
iShares
2.98%
James E. Flynn
2.87%
Peter Kolchinsky
2.69%

Bright Minds Biosciences News & Key Events

  • img

    Today's Timeline - 07 January

    Thu, 08:04 AM

    -

    Bright Minds Biosciences announces pricing of upsized US$175 million public offering at $90.00 per share, closing expected January 9, 2026.

Insights on Bright Minds Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, DRUG stock has moved up by 3487.1%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, DRUG has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 495.8%

About Bright Minds Biosciences

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company’s BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
OrganisationBright Minds Biosciences
Headquarters19 Vestry Street, New York, NY, 10013, US
IndustryBiotechnology
CEOIan McDonald
E-voting on sharesClick here to vote

Key Management of Bright Minds Biosciences

Name

Title

Dr. Emer Leahy M.B.A., Ph.D.

Consultant

Dr. Stephen D. Collins M.D., Ph.D.

Chief Medical Officer

Mr. Ian McDonald

Co-Founder, CEO, President & Director

Mr. Ryan E. S. K. Cheung B.Com., C.A., C.P.A.

CFO & Corporate Secretary

Dr. Jan Torleif Pedersen M.Sc., Ph.D.

Chief Science Officer & Director

Mr. Alex Vasilkevich

COO & Senior Scientific Officer

FAQs

What is Bright Minds Biosciences share price today?

Bright Minds Biosciences share price today is $60.98 as on at the close of the market. Bright Minds Biosciences share today touched a day high of $62.11 and a low of $60.50.

What is the 52 week high and 52 week low for Bright Minds Biosciences share?

Bright Minds Biosciences share touched a 52 week high of $123.75 on and a 52 week low of $44.28 on . Bright Minds Biosciences stock price today i.e. is closed at $60.98,which is 50.72% down from its 52 week high and 37.71% up from its 52 week low.

What is Bright Minds Biosciences's market capitalisation today?

Bright Minds Biosciences market capitalisation is $0.00T as on .

How to invest in Bright Minds Biosciences Stock (DRUG) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bright Minds Biosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bright Minds Biosciences Shares that will get you 0.0246 shares as per Bright Minds Biosciences share price of $60.98 per share as on September 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Bright Minds Biosciences Stock (DRUG) from India?

Indian investors can start investing in Bright Minds Biosciences (DRUG) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Bright Minds Biosciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Bright Minds Biosciences share’s latest price of $60.98 as on September 19, 2026 at 8:46 am IST, you will get 0.1640 shares of Bright Minds Biosciences. Learn more about fractional shares .